Search PubMed⌕ Search

Biomedical subjects

W D Mason

Publications and source records attributed to W D Mason.

At least 37 records · Page 2Linked to original sources

Kinetics of aspirin absorption following oral administration of six aqueous solutions with different buffer capacities.

Fifteen volunteers each received two of six aspirin solutions in a balanced incomplete block design. The solutions contained 0, 3, 6, 10, 16, and 34 mEq of sodium bicarbonate-citric acid buffer and 650 mg of aspirin. Plasma aspirin levels were measured in blood samples collected frequently during the first 2.5 h, and the accumulation of aspirin, salicylic acid, and salicyluric acid were measured over 2 and 24 h. The most rapid absorption rates occurred with solutions which contained small quantities of the antacid buffer. The 3- and 6-mEq antacid buffers had mean maximal aspirin concentrations of 17.3 and 17.8 micrograms/mL, respectively. In the absence of the buffering agent, the 650 mg of aspirin failed to dissolve completely and gave a mean maximal plasma concentration of 13.4 micrograms/mL. With 34 mEq of a buffering agent, a delay in the onset of absorption occurred and the presystemic hydrolysis increased. This was probably because more aspirin was emptied into and absorbed from the small intestine with higher concentrations of the buffering agent.

Adult↗

Influence of food on aspirin absorption from tablets and buffered solutions.

After a standard meal, 12 normal volunteers received three aspirin dosage forms in a single-dose, complete crossover study. The three dosage forms were an unbuffered tablet, an effervescent solution with 16 meq of buffer, and an effervescent solution with 34 meq of buffer. Plasma and urine aspirin, salicylic acid, and salicyluric acid were measured for 10 hr. Significant differences in the absorption kinetics of aspirin were observed, with aspirin from the two solutions being absorbed faster than from the tablet. Urine pH and renal clearance for all three acid compounds were influenced by the buffer during the first 2 hr only. Area under the curve (AUC) and urine accumulation comparisons suggest that 15-20% more aspirin reaches the general circulation after the tablet, but that the total salicylate absorbed is not different. Comparison with an earlier study indicates the solution with 34 meq of buffer is virtually unaffected by the presence of the meal while the solution with 16 meq buffer and the tablet are more slowly absorbed in the nonfasted state.

Adult↗

High-pressure liquid chromatographic determination of viloxazine in human plasma and urine.

A rapid, specific, high-pressure liquid chromatographic method is presented for the determination of viloxazine in plasma and urine. This method employs the high sensitivity of fluorescence detection with selective extraction and reversed-phase chromatography to measure concentrations as low as 25 ng/ml of plasma and 1.0 microgram/ml of urine. Known metabolites of viloxazine do not interfere with the analysis, and experience with several hundred samples in a bioavailability study demonstrated the applicability and reliability of the method.

Chromatography, High Pressure Liquid↗

Kinetics of aspirin, salicylic acid, and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions.

Twelve fasting normal volunteers received three aspirin dosage forms in a single-dose, complete crossover study; the plasma and urine levels of aspirin, salicylic acid, and salicyluric acid were measured for 10 hr. The three dosage forms were an unbuffered tablet, an effervescent solution with 16 mEq of buffer, and an effervescent solution with 34 mEq of buffer. Significant differences in the absorption rate were observed, with the solution having 16 mEQ of buffer being fastest, the solution having 34 mEq of buffer being intermediate, and the tablet being slowest. These differences are attributed to gastric emptying rates and tablet dissolution. Urine pH and renal clearance for all three acid compounds are influenced by the buffer during the first 2 hr following dosing but not later. Area under the curve comparisons suggest that approximately 20% more aspirin reaches the general circulation intact following the tablet but that the total amount of salicylate absorbed is not different. Further studies are required to select the optimal buffer content to provide rapid absorption with minimal sodium dose and urine alkalinization.

Absorption↗

High-pressure liquid chromatographic analysis of phenylpropanolamine in human plasma following derivatization with O-phthalaldehyde.

A high-pressure liquid chromatographic analysis of phenylpropanolamine in human plasma following extraction, back-extraction, and O-phthalaldehyde derivatization is presented. Using fluorescence detection, the method was sufficiently sensitive to quantitate as little as 5 ng of drug/ml of plasma; the coefficient of variation below 100 ng/ml ranged between 5.7 and 2.8%. Plasma concentration data following a single 25-mg dose of phenylpropanolamine hydrochloride in 12 healthy volunteers demonstrate the application of the analytical method.

Biological Availability↗

Effect of exercise on renal clearance of atenolol.

The effect of exercise on plasma atenolol was evaluated using a two-phase complete crossover study in 12 healthy volunteers. In one phase, the volunteers were subjected to physical exertion on a treadmill; in the other phase, they remained in a sitting or standing position. Following a single 100-mg atenolol dose, frequent blood samples and a complete urine collection were obtained over 24 hr. Plasma and urine atenolol levels were assayed by high-pressure liquid chromatography. Plasma atenolol was significantly (p less than 0.05) higher during the exercise phase of the study, and this result was associated with approximately an 8% decrease in the renal clearance of the drug, probably due to decreased renal blood flow during exercise.

Adult↗

Determination of free methyldopa in plasma by high-pressure liquid chromatography and electrochemical detection.

A quantitative method for the analysis of free methyldopa in plasma is described. The method is based on reversed-phase high-pressure liquid chromatography with electrochemical detection utilizing an ion-pairing agent. Separation of methyldopa from plasma is achieved by alumina adsorption. The parameters associated with the adsorption step are described. The lower limit of sensitivity is similar to or approximately 10 ng of methyldopa/ml with a corresponding retention time of 6.9 min.

Acetonitriles↗

Comparative plasma salicylate and urine salicylurate levels following administration of aspirin, magnesium salicylate, and choline magnesium trisalicylate.

Eighteen healthy volunteers were administered single doses of commercially available solid dosage forms of aspirin, magnesium salicylate (I), and choline magnesium trisalicylate (II), equivalent to approximately 500 mg of salicylic acid, in a randomized, complete crossover design. Plasma salicylate and urine salicylurate levels were measured by high-pressure liquid chromatography at frequent intervals following dosing; the resultant profiles, areas under the curve (AUC), and percentages of dose excreted as salicylurate were statistically analyzed by an analysis of variance. The plasma salicylate levels following the two dosage forms containing I and II were virtually identical when corrected for small differences in the dose. The plasma salicylic acid level following aspirin was approximately 10% lower during the 1.5--3.0-hr interval due to a portion of unhydrolyzed aspirin, but the dose-corrected AUC for the products tested did not differ significantly (p < 0.05). During the 24 hr following dosing, 66.5 +/- 12.1 68.4 +/- 7.1, and 60.9 +/- 14.1% of the salicylic acid were excreted as urine salicylurate for aspirin, I, and II, respectively, with no significant difference (p < 0.05). Based on this study, there are no significant differences in the rate and extent of absorption of salicylate following the three dosage forms tested, and the elimination kinetics of salicylic acid are not altered by these dosage forms.

Adolescent↗

Bioavailability of theophylline following a rectally administered concentrated aminophylline solution.

A two-way complete crossover bioavailability study of solutions of theophylline given orally or rectally in 16 healthy subjects was conducted. Blood samples were obtained prior to dosing and at 0.25, 0.5, 0.75, 1, 1.5, 2, 2,5, 3, 3,5, 4, 4.5, 5, 6, 7, 8, 10, 12, and 24 hr. Plasma theophylline was determined by high-pressure liquid chromatography. In the fasting subjects solutions given orally were absorbed faster (0.95 versus 1.95 hr to peak), reaching a higher peak concentration (7.26 versus 4.87 microgram/ml) than the solutions given rectally. Depending on the method of computation, solutions given rectally were estimated to be 86% to 87% as biovailable as the solutions given orally, with 75% of the subjects having 80% or greater relative bioavailability.

Absorption↗

Kinetics and absolute bioavailability of atenolol.

Twelve healthy volunteers received four single doses of atenolol (25-, 50-, and 100-mg oral solutions and a 50-mg intravenous infusion), each dose separated by at least one week. Blood and urine assayed for atenolol by a high pressure liquid chromatography (HPLC) method. Kinetic analysis of the intravenous data indicates a three-compartment model with elimination from the central compartment. The mean (+/- SD) terminal elimination half-life is 6.06 +/- 2.02 hr, the mean volume of the central compartment is 0.173 L/kg, and 94.1 +/- 8.0% of the intravenous dose is excreted in the urine. The mean value of the plasma clearance is 10.7 +/- 1.27 L/hr and of the renal plasma clearance, 10.4 +/- 1.14 L/hr. The mean absolute bioavailability for the 25-, 50-, and 100-mg oral doses is 0.52 +/- 0.18, 0.54 +/- 0.12, and 0.58 +/- 0.16, respectively. The maximum plasma concentration varies as a linear function of dose. Time to mean maximum plasma concentration (3.0 hr) and the time for half of the bioavailable dose to be absorbed (2.0 hr) do not differ significantly with dose. The mean renal plasma clearance after oral doses (9.49 +/- 1.6 L/hr) is in the same range as renal clearance after intravenous doses.

Adult↗

Rapid determination of atenolol in human plasma and urine by high-pressure liquid chromatography.

A rapid, specific, high-pressure liquid chromatographic determination of atenolol in plasma and urine was developed. This method employs the high sensitivity of fluorescence detection together with selective extraction and reversed-phase chromatography to measure concentrations as low as 20 ng of drug/ml of plasma with a coefficient of variation of 3.91%. The assay is specific enough to be valid in the presence of plasma and urine substances. The detection limit (i.e., three times baseline noise) is 3 ng/ml.

Atenolol↗

Rapid determination of procainamide and its N-acetyl derivative in human plasma by high-pressure liquid chromatography.

A rapid, specific, high-pressure liquid chromatographic method for the determination of procainamide and its N-acetyl derivative in plasma was developed. The procedure is fast enough (15 min from receipt of blood to reporting value) to be used for emergency determinations. The sensitivity, precision, and accuracy are sufficient for routine monitoring of therapeutic levels in patients. The assay is specific enough to be valid in the presence of a number of drugs and dietary substances present in clinical samples.

Chromatography, High Pressure Liquid↗

Pharmacokinetics of oxprenolol in normal subjects.

The effect of oxprenolol administered intravenously (10 and 20 mg) and orally (20, 40, 80, and 160 mg) on plasma concentrations of the drug, resting heart rate, exercise-induced tachycardia, and arterial blood pressure was assessed as a function of time in 6 healthy subjects. The pharmacokinetics of oxprenolol following intravenous administration are best described as 2-compartnent open model with dose-dependent parameters. The mean (+/-SD) plasma half-life for oral doses is 1.94 +/- 0.37 and for intravenous doses is 2.31 +/- 0.64 hr. After oral administration, peak plasma concentrations are reached within 30 to 90 min, and the area under the plasma concentration-time curve varies linearly with the dose. Comparison of oral and intravenous data reveals the variation in bioavailabilty of orally administered oxprenolol to range from 19% to 74%. Unlike propranolol, oxprenolol does not show a saturable "first-pass" elimination effect. Blockade of beta-receptors occurs at plasma levels in excess of 60 ng/ml as evidenced by significant reductions in resting heart rate and exercise-induced tachycardia. Higher plasma concentrations of oxprenolol are required to lower blood pressure compared to those necessary to slow heart rate. These data suggest significant pharmacokinetic differences between oxprenolol and other beta-adrenergic receptor antagonists.

Administration, Oral↗

Determination of nitrofurantoin in urine by reduction at rotating platinum electrode.

The application of the reduction of nitrofurantoin at the rotating platinum electrode to the determination of the drug in the urine of clinical patients was evaluated and compared to a commonly used colorimetric method. The new electrochemical method was found to be faster and more efficient with precision and accuracy comparable to those of the colorimetric method.

Colorimetry↗

Rapid determination of theophylline in human plasma by high-pressure liquid chromatography.

A rapid, specific, high-pressure liquid chromatographic method for the determination of theophylline in plasma was developed. The procedure is fast enough (21 min from receipt of blood to reporting value) to be used for emergency determinations. The sensitivity, precision, and accuracy are sufficient for routine monitoring of therapeutic levels in patients. The assay is specific enough to be valid in the presence of caffeine and theobromine. Metabolites of theophylline as well as a number of drugs do not interfere with the assay.

Chromatography, High Pressure Liquid↗

Comparative plasma concentrations of quinidine following administration of one intramuscular and three oral formulations to 13 human subjects.

A GLC method, based on flame-ionization detection, was developed for the assay of methotrimeprazine and its sulfoxide in plasma. For a 6-ml aliquot, the sensitivity was 2-3 ng/ml for the unchanged drug and 4-5 ng/ml for the sulfoxide. The coefficient of variation, calculated from duplicate analyses of plasma samples, was 8-15% for concentrations between 10 and 100 ng/ml. Patients treated with orally administered methotrimeprazine had higher plasma levels of the sulfoxide than of unmetabolized drug. The method also was applied to the analysis of promazine and chlorpromazine in patient plasma.

Administration, Oral↗